Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Blum

Showing results (81-90 of 336) with videos related to

Pageof 34
Sort By:
Plos One|March 26, 2013
Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patientsEric R Braverman, Kenneth Blum, Uma J Damle, et al.
Current Addiction Reports|September 12, 2022
Review: Cannabinoids as MedicinalsJag H Khalsa, Gregory Bunt, Kenneth Blum, et al.
Journal of Personalized Medicine|August 29, 2024
Pilot Study of Personalized Transcranial Magnetic Stimulation with Spectral Electroencephalogram Analyses for Assessing and Treating Persons with AutismMilan T Makale, Chad Nybo, Kenneth Blum, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Ketamine's Role in Neuroinflammation and Neuroprotection Across Neurological and Psychiatric Disorders: A Narrative ReviewGustavo N Silva, Virna G A Brandão, Kenneth Blum, et al.
Current Pharmaceutical Design|August 12, 2016
Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and NeuroplasticityKenneth Blum, Marcelo Febo, Rajendra D Badgaiyan, et al.
Open Journal of Clinical & Medical Case Reports|September 10, 2016
Low-Resolution Electromagnetic Tomography (LORETA) of changed Brain Function Provoked by Pro-Dopamine Regulator (KB220z) in one Adult ADHD caseBruce Steinberg, Kenneth Blum, Thomas McLaughlin, et al.
Frontiers in Bioscience (Landmark Edition)|April 15, 2017
Substance use disorder a bio-directional subset of reward deficiency syndromeKenneth Blum, Mark Gold, Zsolt Demetrovics, et al.
Frontiers in Public Health|February 9, 2024
Opioid use disorder: current trends and potential treatmentsYu Kyung Lee, Mark S Gold, Kenneth Blum, et al.
Clinical Medical Reviews and Case Reports|February 23, 2016
Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic ModalityKenneth Blum, Marcelo Febo, Claudia Fahlke, et al.
Journal of Systems and Integrative Neuroscience|September 5, 2017
The effects of residential dual diagnosis treatment on alcohol abuseStephen J Schoenthaler, Kenneth Blum, Lyle Fried, et al.
Pageof 34

Showing results (81-90 of 336) with videos related to

Sort By:
Pageof 34
Plos One|March 26, 2013
Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patientsEric R Braverman, Kenneth Blum, Uma J Damle, et al.
Current Addiction Reports|September 12, 2022
Review: Cannabinoids as MedicinalsJag H Khalsa, Gregory Bunt, Kenneth Blum, et al.
Journal of Personalized Medicine|August 29, 2024
Pilot Study of Personalized Transcranial Magnetic Stimulation with Spectral Electroencephalogram Analyses for Assessing and Treating Persons with AutismMilan T Makale, Chad Nybo, Kenneth Blum, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Ketamine's Role in Neuroinflammation and Neuroprotection Across Neurological and Psychiatric Disorders: A Narrative ReviewGustavo N Silva, Virna G A Brandão, Kenneth Blum, et al.
Current Pharmaceutical Design|August 12, 2016
Neuronutrient Amino-Acid Therapy Protects Against Reward Deficiency Syndrome: Dopaminergic Key to Homeostasis and NeuroplasticityKenneth Blum, Marcelo Febo, Rajendra D Badgaiyan, et al.
Open Journal of Clinical & Medical Case Reports|September 10, 2016
Low-Resolution Electromagnetic Tomography (LORETA) of changed Brain Function Provoked by Pro-Dopamine Regulator (KB220z) in one Adult ADHD caseBruce Steinberg, Kenneth Blum, Thomas McLaughlin, et al.
Frontiers in Bioscience (Landmark Edition)|April 15, 2017
Substance use disorder a bio-directional subset of reward deficiency syndromeKenneth Blum, Mark Gold, Zsolt Demetrovics, et al.
Frontiers in Public Health|February 9, 2024
Opioid use disorder: current trends and potential treatmentsYu Kyung Lee, Mark S Gold, Kenneth Blum, et al.
Clinical Medical Reviews and Case Reports|February 23, 2016
Hypothesizing Balancing Endorphinergic and Glutaminergic Systems to Treat and Prevent Relapse to Reward Deficiency Behaviors: Coupling D-Phenylalanine and N-Acetyl-L-Cysteine (NAC) as a Novel Therapeutic ModalityKenneth Blum, Marcelo Febo, Claudia Fahlke, et al.
Journal of Systems and Integrative Neuroscience|September 5, 2017
The effects of residential dual diagnosis treatment on alcohol abuseStephen J Schoenthaler, Kenneth Blum, Lyle Fried, et al.
Pageof 34